NCT05204290 2026-03-24
Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Terminated
Clinical Trials
10 trialsNCT07236177 2026-02-05
B-GLUCANCER2
Poitiers University Hospital
Phase EARLY_PHASE1 Recruiting
NCT03804424 2024-11-12
64Cu-LLP2A for Imaging Multiple Myeloma
Washington University School of Medicine
Phase EARLY_PHASE1 Terminated
NCT03629717 2024-10-16
RANKL Inhibition and Breast Tissue Biomarkers
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT03371420 2023-04-18
PET Imaging of Subjects Using 124I-PU-AD
Samus Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT04051047 2019-11-27
Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT01263613 2019-11-19
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT00651976 2018-10-15
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated
NCT01302002 2016-02-23
The Use of Metformin in Early Breast Cancer Patients Pre-Surgery
Instituto Nacional de Cancer, Brazil
Phase EARLY_PHASE1 Withdrawn
NCT01329718 2014-08-04
SPR0012
Epigenomics, Inc
Phase EARLY_PHASE1 Completed